Gene	Gene synonym	Ensembl	Gene description	Uniprot	Chromosome	Position	Protein class	Biological process	Molecular function	Disease involvement	Evidence	HPA evidence	UniProt evidence	NeXtProt evidence	MS evidence	RNA tissue specificity	RNA tissue distribution	RNA tissue specificity score	RNA tissue specific NX	RNA single cell type specificity	RNA single cell type distribution	RNA single cell type specificity score	RNA single cell type specific NX	RNA cancer specificity	RNA cancer distribution	RNA cancer specificity score	RNA cancer specific FPKM	RNA brain regional specificity	RNA brain regional distribution	RNA brain regional specificity score	RNA brain regional specific NX	RNA blood cell specificity	RNA blood cell distribution	RNA blood cell specificity score	RNA blood cell specific NX	RNA blood lineage specificity	RNA blood lineage distribution	RNA blood lineage specificity score	RNA blood lineage specific NX	RNA cell line specificity	RNA cell line distribution	RNA cell line specificity score	RNA cell line specific NX	RNA mouse brain regional specificity	RNA mouse brain regional distribution	RNA mouse brain regional specificity score	RNA mouse brain regional specific pTPM	RNA pig brain regional specificity	RNA pig brain regional distribution	RNA pig brain regional specificity score	RNA pig brain regional specific pTPM	Antibody	Reliability (IH)	Reliability (Mouse Brain)	Reliability (IF)	Subcellular location	Secretome location	CCD Protein	CCD Transcript	Blood concentration - Conc. blood IM [pg/L]	Blood concentration - Conc. blood MS [pg/L]	Subcellular main location	Subcellular additional location	Antibody RRID	Pathology prognostics - Breast cancer	Pathology prognostics - Cervical cancer	Pathology prognostics - Colorectal cancer	Pathology prognostics - Endometrial cancer	Pathology prognostics - Glioma	Pathology prognostics - Head and neck cancer	Pathology prognostics - Liver cancer	Pathology prognostics - Lung cancer	Pathology prognostics - Melanoma	Pathology prognostics - Ovarian cancer	Pathology prognostics - Pancreatic cancer	Pathology prognostics - Prostate cancer	Pathology prognostics - Renal cancer	Pathology prognostics - Stomach cancer	Pathology prognostics - Testis cancer	Pathology prognostics - Thyroid cancer	Pathology prognostics - Urothelial cancer	Tissue RNA - adipose tissue [NX]	Tissue RNA - adrenal gland [NX]	Tissue RNA - amygdala [NX]	Tissue RNA - appendix [NX]	Tissue RNA - basal ganglia [NX]	Tissue RNA - bone marrow [NX]	Tissue RNA - breast [NX]	Tissue RNA - cerebellum [NX]	Tissue RNA - cerebral cortex [NX]	Tissue RNA - cervix, uterine [NX]	Tissue RNA - colon [NX]	Tissue RNA - corpus callosum [NX]	Tissue RNA - ductus deferens [NX]	Tissue RNA - duodenum [NX]	Tissue RNA - endometrium 1 [NX]	Tissue RNA - epididymis [NX]	Tissue RNA - esophagus [NX]	Tissue RNA - fallopian tube [NX]	Tissue RNA - gallbladder [NX]	Tissue RNA - heart muscle [NX]	Tissue RNA - hippocampal formation [NX]	Tissue RNA - hypothalamus [NX]	Tissue RNA - kidney [NX]	Tissue RNA - liver [NX]	Tissue RNA - lung [NX]	Tissue RNA - lymph node [NX]	Tissue RNA - midbrain [NX]	Tissue RNA - olfactory region [NX]	Tissue RNA - ovary [NX]	Tissue RNA - pancreas [NX]	Tissue RNA - parathyroid gland [NX]	Tissue RNA - pituitary gland [NX]	Tissue RNA - placenta [NX]	Tissue RNA - pons and medulla [NX]	Tissue RNA - prostate [NX]	Tissue RNA - rectum [NX]	Tissue RNA - retina [NX]	Tissue RNA - salivary gland [NX]	Tissue RNA - seminal vesicle [NX]	Tissue RNA - skeletal muscle [NX]	Tissue RNA - skin 1 [NX]	Tissue RNA - small intestine [NX]	Tissue RNA - smooth muscle [NX]	Tissue RNA - spinal cord [NX]	Tissue RNA - spleen [NX]	Tissue RNA - stomach 1 [NX]	Tissue RNA - testis [NX]	Tissue RNA - thalamus [NX]	Tissue RNA - thymus [NX]	Tissue RNA - thyroid gland [NX]	Tissue RNA - tongue [NX]	Tissue RNA - tonsil [NX]	Tissue RNA - urinary bladder [NX]	Tissue RNA - vagina [NX]	Tissue RNA - B-cells [NX]	Tissue RNA - dendritic cells [NX]	Tissue RNA - granulocytes [NX]	Tissue RNA - monocytes [NX]	Tissue RNA - NK-cells [NX]	Tissue RNA - T-cells [NX]	Tissue RNA - total PBMC [NX]	Cell RNA - A-431 [NX]	Cell RNA - A549 [NX]	Cell RNA - AF22 [NX]	Cell RNA - AN3-CA [NX]	Cell RNA - ASC diff [NX]	Cell RNA - ASC TERT1 [NX]	Cell RNA - BEWO [NX]	Cell RNA - BJ [NX]	Cell RNA - BJ hTERT+ [NX]	Cell RNA - BJ hTERT+ SV40 Large T+ [NX]	Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]	Cell RNA - CACO-2 [NX]	Cell RNA - CAPAN-2 [NX]	Cell RNA - Daudi [NX]	Cell RNA - EFO-21 [NX]	Cell RNA - fHDF/TERT166 [NX]	Cell RNA - GAMG [NX]	Cell RNA - HaCaT [NX]	Cell RNA - HAP1 [NX]	Cell RNA - HBEC3-KT [NX]	Cell RNA - HBF TERT88 [NX]	Cell RNA - HDLM-2 [NX]	Cell RNA - HEK 293 [NX]	Cell RNA - HEL [NX]	Cell RNA - HeLa [NX]	Cell RNA - Hep G2 [NX]	Cell RNA - HHSteC [NX]	Cell RNA - HL-60 [NX]	Cell RNA - HMC-1 [NX]	Cell RNA - HSkMC [NX]	Cell RNA - hTCEpi [NX]	Cell RNA - hTEC/SVTERT24-B [NX]	Cell RNA - hTERT-HME1 [NX]	Cell RNA - hTERT-RPE1 [NX]	Cell RNA - HUVEC TERT2 [NX]	Cell RNA - JURKAT [NX]	Cell RNA - K-562 [NX]	Cell RNA - Karpas-707 [NX]	Cell RNA - LHCN-M2 [NX]	Cell RNA - MCF7 [NX]	Cell RNA - MOLT-4 [NX]	Cell RNA - NB-4 [NX]	Cell RNA - NTERA-2 [NX]	Cell RNA - OE19 [NX]	Cell RNA - PC-3 [NX]	Cell RNA - REH [NX]	Cell RNA - RH-30 [NX]	Cell RNA - RPMI-8226 [NX]	Cell RNA - RPTEC TERT1 [NX]	Cell RNA - RT4 [NX]	Cell RNA - SCLC-21H [NX]	Cell RNA - SH-SY5Y [NX]	Cell RNA - SiHa [NX]	Cell RNA - SK-BR-3 [NX]	Cell RNA - SK-MEL-30 [NX]	Cell RNA - SuSa [NX]	Cell RNA - T-47d [NX]	Cell RNA - THP-1 [NX]	Cell RNA - TIME [NX]	Cell RNA - U-138 MG [NX]	Cell RNA - U-2 OS [NX]	Cell RNA - U-2197 [NX]	Cell RNA - U-251 MG [NX]	Cell RNA - U-266/70 [NX]	Cell RNA - U-266/84 [NX]	Cell RNA - U-698 [NX]	Cell RNA - U-87 MG [NX]	Cell RNA - U-937 [NX]	Cell RNA - WM-115 [NX]	Blood RNA - basophil [NX]	Blood RNA - classical monocyte [NX]	Blood RNA - eosinophil [NX]	Blood RNA - gdT-cell [NX]	Blood RNA - intermediate monocyte [NX]	Blood RNA - MAIT T-cell [NX]	Blood RNA - memory B-cell [NX]	Blood RNA - memory CD4 T-cell [NX]	Blood RNA - memory CD8 T-cell [NX]	Blood RNA - myeloid DC [NX]	Blood RNA - naive B-cell [NX]	Blood RNA - naive CD4 T-cell [NX]	Blood RNA - naive CD8 T-cell [NX]	Blood RNA - neutrophil [NX]	Blood RNA - NK-cell [NX]	Blood RNA - non-classical monocyte [NX]	Blood RNA - plasmacytoid DC [NX]	Blood RNA - T-reg [NX]	Blood RNA - total PBMC [NX]	Brain RNA - amygdala [NX]	Brain RNA - basal ganglia [NX]	Brain RNA - cerebellum [NX]	Brain RNA - cerebral cortex [NX]	Brain RNA - hippocampal formation [NX]	Brain RNA - hypothalamus [NX]	Brain RNA - midbrain [NX]	Brain RNA - olfactory region [NX]	Brain RNA - pons and medulla [NX]	Brain RNA - thalamus [NX]	Single Cell Type RNA - Alveolar cells type 1 [NX]	Single Cell Type RNA - Alveolar cells type 2 [NX]	Single Cell Type RNA - B-cells [NX]	Single Cell Type RNA - Basal glandular cells [NX]	Single Cell Type RNA - Basal keratinocytes [NX]	Single Cell Type RNA - Bipolar cells [NX]	Single Cell Type RNA - Cardiomyocytes [NX]	Single Cell Type RNA - Cholangiocytes [NX]	Single Cell Type RNA - Ciliated cells [NX]	Single Cell Type RNA - Club cells [NX]	Single Cell Type RNA - Collecting duct cells [NX]	Single Cell Type RNA - Cone photoreceptor cells [NX]	Single Cell Type RNA - Cytotrophoblasts [NX]	Single Cell Type RNA - Distal tubular cells [NX]	Single Cell Type RNA - Ductal cells [NX]	Single Cell Type RNA - Early spermatids [NX]	Single Cell Type RNA - Endothelial cells [NX]	Single Cell Type RNA - Enterocytes [NX]	Single Cell Type RNA - Erythroid cells [NX]	Single Cell Type RNA - Exocrine glandular cells [NX]	Single Cell Type RNA - Extravillous trophoblasts [NX]	Single Cell Type RNA - Fibroblasts [NX]	Single Cell Type RNA - Glandular cells [NX]	Single Cell Type RNA - granulocytes [NX]	Single Cell Type RNA - Hepatocytes [NX]	Single Cell Type RNA - Hofbauer cells [NX]	Single Cell Type RNA - Horizontal cells [NX]	Single Cell Type RNA - Intestinal endocrine cells [NX]	Single Cell Type RNA - Ito cells [NX]	Single Cell Type RNA - Kupffer cells [NX]	Single Cell Type RNA - Late spermatids [NX]	Single Cell Type RNA - Leydig cells [NX]	Single Cell Type RNA - Macrophages [NX]	Single Cell Type RNA - Melanocytes [NX]	Single Cell Type RNA - monocytes [NX]	Single Cell Type RNA - Mucus-secreting cells [NX]	Single Cell Type RNA - Muller glia cells [NX]	Single Cell Type RNA - Pancreatic endocrine cells [NX]	Single Cell Type RNA - Paneth cells [NX]	Single Cell Type RNA - Peritubular cells [NX]	Single Cell Type RNA - Proximal tubular cells [NX]	Single Cell Type RNA - Rod photoreceptor cells [NX]	Single Cell Type RNA - Sertoli cells [NX]	Single Cell Type RNA - Smooth muscle cells [NX]	Single Cell Type RNA - Spermatocytes [NX]	Single Cell Type RNA - Spermatogonia [NX]	Single Cell Type RNA - Suprabasal keratinocytes [NX]	Single Cell Type RNA - Syncytiotrophoblasts [NX]	Single Cell Type RNA - T-cells [NX]	Single Cell Type RNA - Undifferentiated cells [NX]	Single Cell Type RNA - Urothelial cells [NX]	RNAsingleCellTypeSpecific
TBXA2R		ENSG00000006638	Thromboxane A2 receptor	P21731	19	3594506-3606840	Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins		G-protein coupled receptor, Receptor, Transducer	Disease mutation, FDA approved drug targets	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell type enriched	Detected in some	7	Ito cells: 35.0	Low cancer specificity	Detected in all			Low region specificity	Detected in many			Cell type enhanced	Detected in many		naive B-cell: 12.6	Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		HeLa: 11.9;U-2197: 8.6;U-937: 7.4	Low region specificity	Detected in single			Low region specificity	Detected in many			HPA077366			Supported	Nuclear speckles,Plasma membrane						Plasma membrane	Nuclear speckles	HPA077366: AB_2686836	unprognostic (1.59e-1)	unprognostic (3.86e-2)	unprognostic (1.21e-2)	unprognostic (1.74e-1)	unprognostic (8.97e-2)	unprognostic (4.19e-2)	unprognostic (1.52e-2)	unprognostic (2.17e-3)	unprognostic (8.41e-2)	unprognostic (6.25e-2)	prognostic favorable (7.17e-4)	unprognostic (3.89e-2)	prognostic unfavorable (1.45e-4)	unprognostic (4.32e-2)	unprognostic (9.63e-2)	unprognostic (1.76e-1)	unprognostic (2.02e-1)	8.7	11.8	1.4	3.9	1.6	2.1	3.9	0.5	1.6	13.5	3.8	1.7	3.9	2.6	7.4	4.8	8	4.7	6	6.8	2.4	1.5	10.1	18.4	6.7	7.3	1.4	1.9	8.3	2.2	2.5	1.7	10.6	2.7	3.6	1.4	5	1.7	4.2	3.1	1.8	4.4	6.5	2.1	14.9	3.7	3.4	1.9	2.2	3.9	3.2	1.8	6.8	9.6	12.6	0.3	3.2	0.4	3.1	9.6	3.9	0.1	0.2	0.2	4.1	0.9	2.2	0.7	3	0.8	2.3	1.8	0.1	0.3	0.1	4.4	1.2	2.3	0.1	0.9	0	0.9	0.2	1	2.9	11.9	0.3	1.2	0	5.3	1.1	0	3	0	1.7	0.9	0	4.5	0.4	0.4	0.2	0.2	1.5	0.1	0.1	2.6	0.1	0	0.2	0	0.1	0.2	1.7	0.2	0.4	0.1	0.3	1.8	5.1	2.6	4.8	1.1	8.6	2.8	0.2	0.3	0.2	4	7.4	1.1	2.9	0.4	0.2	2.6	0.2	0.3	1.8	0.8	2.3	0	12.6	4.6	9.6	3.2	3.1	0.2	0.3	0.2	3.9	1.4	1.6	0.5	1.6	2.4	1.5	1.4	1.9	2.7	1.9	0	0	1.3	0.1	0.5	0.4	0.8	0	0	0	1.8	0	0.1	0	0	0	4.8	0	0	0	0.1	2.3	0.1	0	0	0.7	0	0	35	1.2	0	0.3	0	1.7	0	0	0.3	0.1	0	0.7	0	0.1	0	3.1	0.1	1.3	0.5	0.1	0	0	0	Ito cells
STAB1	CLEVER-1, FEEL-1, FELE-1, FEX1, KIAA0246, SCARH2, STAB-1	ENSG00000010327	Stabilin 1	Q9NY15	3	52495338-52524495	Predicted membrane proteins	Inflammatory response	Receptor		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		lymphoid tissue: 90.8	Cell type enriched	Detected in many	5	Ito cells: 1114.7	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Group enriched	Detected in some	68	classical monocyte: 10.8;intermediate monocyte: 6.6;myeloid DC: 2.8	Group enriched	Detected in many	69	dendritic cells: 2.8;monocytes: 10.8	Group enriched	Detected in some	47	HUVEC TERT2: 33.9;NB-4: 46.8;TIME: 41.7	Low region specificity	Detected in all			Low region specificity	Detected in many			HPA005434	Approved		Approved	Nucleoplasm,Plasma membrane,Cytosol					60000000	Cytosol	Nucleoplasm, Plasma membrane	HPA005434: AB_1080097	unprognostic (1.18e-1)	unprognostic (2.89e-1)	prognostic unfavorable (7.59e-4)	unprognostic (3.63e-2)	unprognostic (1.21e-1)	unprognostic (1.49e-2)	unprognostic (1.08e-2)	unprognostic (2.23e-1)	unprognostic (2.38e-1)	unprognostic (4.00e-3)	unprognostic (2.66e-2)	unprognostic (3.19e-1)	prognostic unfavorable (3.88e-7)	unprognostic (3.16e-2)	unprognostic (9.40e-2)	unprognostic (4.70e-2)	unprognostic (1.08e-1)	39.5	37.6	8	26.7	12.8	6.5	41.3	3.2	6.8	13.1	23.4	6.9	4.2	16.1	13.6	26.4	9.7	15.5	16.8	19.7	5.4	4.2	19.2	35.8	21.7	80.7	9.1	2.7	9.9	7.1	4.9	11.9	32.1	10.2	13.5	18	23.7	10.4	9.7	8	5.1	18.7	18.3	7.2	90.8	11.6	9.7	8.7	2.6	11.9	11.4	11.1	15.9	15.4	0	2.8	0	10.8	0	0	2.1	0	0	0	0	0	0	0.4	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0.8	0	0	0.2	0	0	0.6	0	0	0	0	33.9	0	0.1	0	0	0	0	46.8	0	0	0	0	0	0	0	0	0.1	0.1	0	0.1	0	0	0	0	41.7	0	0	0	0	0	0	0	0	0	0	0	10.8	0	0	6.6	0	0	0	0	2.8	0	0	0	0	0	0	0	0	2.1	8	12.8	3.2	6.8	5.4	4.2	9.1	2.7	10.2	8.7	0	6.7	12.3	0.5	5.4	1	2	12.7	0	0	3.5	0	1.3	0	0	0.4	14.5	0	46.7	0	1.5	3.8	0	17.4	8.3	103.3	0	1.2	1114.7	238.9	1.9	4	46.3	11.8	0	0	0.5	0	0	19.1	0.3	0	19.4	1.5	0.7	1.1	4.3	1.8	4.3	0	0.2	Ito cells
EHD3	PAST3	ENSG00000013016	EH domain containing 3	Q9NZN3	2	31234337-31269447	Plasma proteins, Predicted intracellular proteins	Cilium biogenesis/degradation, Protein transport, Transport			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 37.4;esophagus: 29.1	Cell type enriched	Detected in many	5	Ito cells: 172.5	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Group enriched	Detected in many	6	memory B-cell: 17.8;naive B-cell: 4.4	Lineage enriched	Detected in many	9	B-cells: 17.8	Cell line enhanced	Detected in many		BJ: 25.6;BJ hTERT+: 63.5;HEL: 24.6;U-266/70: 15.9	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA049890, HPA049986, HPA066751	Approved		Approved	Plasma membrane					41000000	Plasma membrane		HPA049890: AB_2680936, HPA049986: AB_2680983, HPA066751: AB_2685713	unprognostic (3.44e-1)	unprognostic (8.88e-2)	unprognostic (2.21e-1)	unprognostic (3.79e-2)	unprognostic (3.70e-2)	unprognostic (1.89e-1)	unprognostic (5.49e-2)	unprognostic (1.21e-1)	unprognostic (3.74e-2)	unprognostic (9.72e-2)	unprognostic (9.92e-3)	unprognostic (1.06e-1)	prognostic unfavorable (1.02e-4)	unprognostic (4.88e-3)	unprognostic (9.41e-2)	unprognostic (4.79e-3)	unprognostic (4.92e-3)	2.7	7.1	15	5.6	16.3	2	3.3	10.6	37.4	5.6	2.2	7.3	0	1.9	3.9	3.4	29.1	4.9	3.6	14.8	16.7	8.9	15	10.8	4.8	6.3	9.6	21.6	2.9	1.4	8.7	6	11.3	13.3	5.7	2.1	2.8	4.8	4.9	2.3	3	2.9	4.8	9.4	5.8	1.9	1.6	6.6	1.2	2.5	1.5	10.4	7.8	4.2	17.8	0.4	1	1.9	0.6	1.7	7.8	0.5	2.7	1.5	1.3	2.5	3.9	0.2	25.6	63.5	2.5	2.3	0	0.3	0.2	0.9	8.4	2.2	0.2	0	1.7	1.8	1	2.3	24.6	0.1	0	8.8	0	0	6.2	0.7	2.4	1	6.7	0	0	0	0.1	1.8	4	0.3	0	5.8	0	1.3	0.8	0.1	0.5	1.9	2.9	0.7	3.9	0.2	0.4	0	4.9	0.3	0	0	1.9	1.8	0.1	2	15.9	2	0	4.9	0	4	0.4	0.4	0.3	1.7	0.8	0.9	17.8	0.9	1.1	0.4	4.4	0.8	0.4	1	0.6	1.9	0	0.4	7.8	15	16.3	10.6	32.7	16.7	8.9	9.6	21.6	13.3	6.6	0	0	23.6	1.4	0.7	9.2	18.9	2.5	0	1.2	0	0	3.5	0	0.3	0	5.2	0	0	0.2	7.3	2.3	0.8	0	0.8	1.4	0	1.7	172.5	21.8	0	1.1	0.2	0	1	0	8.1	0.2	0	2.8	0.2	5.4	19.4	3.3	0.2	2.1	0.6	36.7	2.5	0	3.2	Ito cells
CLEC4M	CD209L, CD299, DC-SIGN2, DC-SIGNR, DCSIGNR, HP10347, LSIGN	ENSG00000104938	C-type lectin domain family 4 member M	Q9H2X3	19	7763149-7769605	CD markers, Predicted intracellular proteins, Predicted membrane proteins	Adaptive immunity, Endocytosis, Host-virus interaction, Immunity, Innate immunity	Host cell receptor for virus entry, Receptor		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	7	liver: 38.5;lymphoid tissue: 30.1	Cell type enriched	Detected in some	17	Ito cells: 378.7	Not detected	Not detected			Not detected	Not detected			Cell type enriched	Detected in single	7	memory B-cell: 1.7	Lineage enriched	Detected in single	18	B-cells: 1.7	Group enriched	Detected in some	7	GAMG: 3.5;HUVEC TERT2: 2.3;K-562: 3.1;Karpas-707: 1.2;RPMI-8226: 1.6									CAB033689, CAB033691, HPA042661	Supported				Intracellular and membrane				890000			CAB033689: AB_831088, CAB033691: AB_2081354, HPA042661: AB_2678101	unprognostic (1.56e-1)				unprognostic (3.03e-1)	unprognostic (1.00e-1)	unprognostic (1.71e-2)	unprognostic (1.26e-2)	unprognostic (1.64e-1)	unprognostic (6.58e-2)		unprognostic (1.27e-1)	unprognostic (4.58e-3)	unprognostic (4.60e-2)	unprognostic (5.15e-2)		unprognostic (1.43e-1)	0.9	0.9	0.1	0.5	0.1	0	0.1	0.2	0.1	0.1	0.3	0.1	0.1	0	0.3	0.1	1.2	0.6	0.1	0.1	0.1	0	0.1	38.5	2.5	30.1	0.1	0.1	2.7	0.1	0	0.1	4.8	0.2	0.1	0	0.1	0.8	0.1	0.1	0	0.5	0.1	0.1	0.2	0	1.4	0.1	0.1	0.2	0.1	0.2	0.1	0.1	1.7	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	3.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	2.3	0	3.1	1.2	0	0	0	0	0	0	0	0	0.2	1.6	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	1.7	0	0	0	0.2	0	0	0	0	0	0	0	0	0.1	0.1	0.2	0.1	0.1	0	0.1	0.1	0.2	0.1	0	0	0	0.1	0.1	0	0.3	5.1	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0.3	0	0.8	0.5	0	0	378.7	22.4	0.6	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0.3	0.1	0	0.2	0	0	0.1	Ito cells
LIFR	CD118	ENSG00000113594	LIF receptor alpha	P42702	5	38474963-38608354	Cancer-related genes, CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins		Receptor	Cancer-related genes, Disease mutation	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in many			Cell type enriched	Detected in many	6	Ito cells: 765.5	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in many		AF22: 40.6;HHSteC: 17.3;SCLC-21H: 26.6	Low region specificity	Detected in all			Low region specificity	Detected in all								Intracellular and membrane				74000				unprognostic (6.00e-3)	unprognostic (2.53e-1)	unprognostic (1.05e-1)	unprognostic (2.81e-3)	unprognostic (8.80e-2)	unprognostic (7.13e-2)	unprognostic (1.11e-1)	prognostic favorable (1.92e-4)	unprognostic (1.78e-1)	unprognostic (9.80e-2)	unprognostic (2.73e-3)	unprognostic (1.06e-1)	prognostic favorable (1.40e-7)	unprognostic (3.69e-2)	unprognostic (1.15e-1)	unprognostic (2.03e-2)	unprognostic (1.65e-1)	35.3	14.7	15.8	8.2	19.2	0.5	33.9	10.1	21.3	27.7	10.4	25.3	22.8	4.9	34.8	14.8	10.4	26	10.2	16.3	19.1	11	20.3	23.9	21.7	20.2	24.3	11.8	17.9	17.8	13.5	12.5	41.5	23.4	23.6	7.5	17.1	24.9	24.7	24	10.5	11.7	26.9	21.4	22.5	18.8	9.3	25.3	4.7	31.4	7.3	8.1	13.6	15.8	0	0	0	0	0	0.2	0	0.6	2.3	40.6	3	11.4	12.7	0.3	3.4	1.9	2.7	1.7	0.4	2.2	0	0.5	4.8	6.9	0.3	2.6	0.9	4.7	0	3.7	0	4.3	1.6	17.3	0	0.2	10.6	0.7	6.6	0.7	2.6	3.8	0.4	1.1	6.5	3.4	0.5	0	0.1	1	0	7.2	0	8.6	0	2.6	1	26.6	3.3	14	0.7	0	5.3	0.9	0	0.8	4.4	8.7	10.3	2	0	0	0	7.2	0	2.5	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	15.8	19.2	10.1	21.3	19.1	11	24.3	11.8	23.4	25.3	11.9	34.9	9.3	5.9	20.6	5.8	24.6	10.2	10.7	10.3	14	7.9	7.7	5	1.9	12.6	122.5	0	0	7.8	22.5	46.1	21.1	1.1	6.8	3.2	1.6	0	765.5	62	21.6	105.3	2.6	16.9	0	0	5.1	6.9	0	18.7	13.5	35.3	38.8	42.2	8.9	6.1	15.8	23.9	7.5	0	4.7	Ito cells
DBH	DBM	ENSG00000123454	Dopamine beta-hydroxylase	P09172	9	133636360-133659344	Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins	Catecholamine biosynthesis	Monooxygenase, Oxidoreductase	Disease mutation, FDA approved drug targets	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	9	adrenal gland: 86.6;brain: 36.2;liver: 35.6	Cell type enriched	Detected in single	43	Ito cells: 17.2	Low cancer specificity	Detected in some			Region enriched	Detected in single	45	pons and medulla: 36.2	Cell type enhanced	Detected in single		naive CD4 T-cell: 2.0	Lineage enriched	Detected in single	21	T-cells: 2.0	Cell line enriched	Detected in single	340	SH-SY5Y: 206.1	Region enriched	Detected in some	6	pons and medulla: 23.2	Region enriched	Detected in single	38	pons and medulla: 25.1	HPA002130, HPA005960, HPA070789	Enhanced		Supported	Endoplasmic reticulum,Vesicles	Intracellular and membrane				2000000000	Vesicles	Endoplasmic reticulum	HPA002130: AB_2666554, HPA005960: AB_1078628, HPA070789: AB_2686312	unprognostic (1.93e-3)	unprognostic (7.52e-3)	unprognostic (8.53e-2)	unprognostic (2.10e-2)	unprognostic (2.18e-3)	unprognostic (3.38e-3)	unprognostic (3.39e-3)	unprognostic (3.97e-2)	unprognostic (1.71e-1)	unprognostic (8.99e-2)	unprognostic (5.80e-2)	unprognostic (7.69e-2)	unprognostic (2.81e-7)	unprognostic (9.31e-2)	unprognostic (6.77e-2)	unprognostic (1.49e-2)	unprognostic (5.06e-3)	0.7	86.6	0.1	0.3	0.1	0	0	0.1	0.8	0.3	0	1.9	0.7	0.1	0.1	0	0	0.1	0.1	0.1	0	0.1	0.5	35.6	0.3	0.6	0	0	0.1	1.3	0	0.6	0.4	36.2	0.8	0	1	0.2	5.9	0	0	0.2	0	1.4	0.4	0.1	0	0	0.1	0.1	0	0	0.8	0.5	0	0	0	0	0	2	0	0	0	0	0.1	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0.3	0.1	0	0	0	0	0.6	0.5	0	0	0.2	206.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0	0	2	0	0	0	0	0	0	0	0.1	0.1	0.1	0.8	0	0.1	0	0	36.2	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.2	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Ito cells
STAB2	DKFZP434E0321, FEEL-2, FELL, HARE, SCARH1, STAB-2	ENSG00000136011	Stabilin 2	Q8WWQ8	12	103587273-103766727	Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins	Endocytosis	Receptor		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	6	lymphoid tissue: 71.3	Cell type enriched	Detected in some	10	Ito cells: 196.4	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		BEWO: 16.1;HaCaT: 4.4;RH-30: 2.5	Not detected	Not detected							HPA026871, HPA072699	Enhanced		Supported	Cytosol					210000	Cytosol		HPA026871: AB_1857536, HPA072699: 	unprognostic (5.66e-3)	unprognostic (7.51e-2)	unprognostic (3.31e-1)	unprognostic (3.84e-2)	unprognostic (8.47e-2)	unprognostic (2.15e-2)	unprognostic (1.23e-1)	unprognostic (2.81e-1)	unprognostic (5.72e-2)	unprognostic (1.92e-1)	unprognostic (4.24e-2)	unprognostic (1.05e-1)	unprognostic (9.72e-4)	unprognostic (1.37e-2)	unprognostic (5.00e-1)	unprognostic (1.26e-1)	unprognostic (2.06e-1)	0.6	0.2	0.1	0.5	0.1	0.4	0.5	0.1	0.1	0.7	1.4	0.1	0.1	0.1	1.1	1.1	2.5	0.9	0.6	0.4	0.1	0.1	0.1	11.7	0.5	19.9	0.1	0.1	0.4	0.2	0	0.2	0.4	0.2	0.5	0.2	0.1	2.1	0.3	0.1	0.2	0.3	0.2	0.1	71.3	0.3	1.5	0.1	0.2	0.7	0.5	0.4	0.3	0.4	0.9	0.1	0	0	0.1	0	0	0.2	0.7	0.8	0.2	0	0	16.1	0.7	0	0	0	0	0	0.4	0.1	0	0.3	4.4	0	0	0	0	1.1	0.4	0.7	1	0	0	0	0.1	0	0	0	0.6	0	0.3	1	0	0	0	0	0.1	0.7	0.4	0.5	0.1	2.5	0	0	0.2	0.2	0.1	0	0.2	0.1	0.9	0.3	0.1	0.6	0.8	0.4	0	1.1	0.2	0.2	0	0.3	0.9	0.2	0	0	0	0	0	0	0.2	0	0	0.1	0.9	0	0	0	0.1	0	0	0	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0	0	0	0	0.2	0	0.8	7.6	0	0	0	0	0	0	0	4.6	0.4	0	0	0	0.2	0	0	0	1.5	0.1	0	0	196.4	19.9	9.4	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0.1	0	0	0	0	Ito cells
SMAD6	HsT17432, MADH6, MADH7	ENSG00000137834	SMAD family member 6	O43541	15	66702228-66782848	Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors	Transcription, Transcription regulation	DNA-binding	Craniosynostosis, Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		lung: 37.1	Cell type enriched	Detected in many	6	Ito cells: 107.4	Low cancer specificity	Detected in all			Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in many		EFO-21: 21.2;HaCaT: 12.6;HeLa: 17.4;U-2197: 12.3	Low region specificity	Detected in many			Low region specificity	Detected in many			HPA061917			Supported	Nucleoplasm,Nuclear bodies,Golgi apparatus						Nucleoplasm	Nuclear bodies, Golgi apparatus	HPA061917: AB_2684637	unprognostic (1.20e-1)	unprognostic (7.43e-3)	unprognostic (5.62e-2)	unprognostic (1.26e-1)	unprognostic (3.02e-1)	unprognostic (3.50e-3)	unprognostic (9.59e-2)	unprognostic (4.50e-1)	unprognostic (3.47e-2)	unprognostic (1.50e-1)	unprognostic (1.10e-3)	unprognostic (1.68e-1)	unprognostic (1.67e-2)	unprognostic (1.55e-3)	unprognostic (4.30e-2)	unprognostic (1.33e-1)	prognostic favorable (5.45e-5)	9.8	1.9	2.5	3.1	4.6	0.6	5.1	0.8	2.8	6.3	4.7	2.6	2.1	3.8	5.2	1.9	3.1	4.4	11.6	21.6	3	2	6.1	6.2	37.1	1.2	3.6	2.3	5.1	3.1	2.3	2.8	13.8	4.5	9.7	2.5	18.5	1.6	22.1	1.8	1.6	3.8	3.1	2.9	3.2	8	1.7	2	0	16.7	0.6	0.8	6.8	7.3	0	0.2	0	0.3	0	0	0	0.9	7	1.1	2.4	4.3	1.1	6.7	4.9	0.1	0.8	0	1.4	3.1	0.5	21.2	4.2	0.6	12.6	1.5	0	0.1	1.5	5.8	10.9	17.4	1.1	0.5	0	0.8	1.4	0	0	0	2.4	0.9	3.6	0.9	0.7	0.3	1.3	0.1	3	2.1	7.1	2.6	0	1.3	1.5	2.4	5.5	2.6	1.1	2.7	3	0.5	4.3	1	2	4.2	3.1	4	12.3	0.9	0.4	1.2	0.2	2.2	3.9	0.1	0	0.3	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0.2	0	0	0	2.5	4.6	0.8	2.8	3	2	3.6	2.3	4.5	2	11.9	5.9	1.4	1	0.7	0	4.5	5.1	0	4.5	1.8	2	0.5	3.3	4.3	2.8	19.4	2.8	0	5	0.7	4.3	1.5	4.6	2.8	1.7	0	0	107.4	9.5	1	2.6	0.8	0	1	2	11.1	5.6	0	7.8	1.5	0.3	0	1	0.2	0.6	0.1	0.7	0.5	5.3	0.3	Ito cells
OIT3	FLJ39116, LZP	ENSG00000138315	Oncoprotein induced transcript 3	Q8WWZ8	10	72893581-72933033	Plasma proteins, Predicted secreted proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	8	liver: 49.1	Cell type enriched	Detected in some	10	Ito cells: 487.3	Cancer enhanced	Detected in many		liver cancer: 4.6	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	6	CACO-2: 5.8;Hep G2: 6.1	Not detected	Not detected			Not detected	Not detected								Secreted to blood				150000000				unprognostic (2.42e-2)	unprognostic (6.76e-2)	unprognostic (7.98e-4)	unprognostic (9.26e-2)	unprognostic (9.47e-4)	unprognostic (3.05e-1)	unprognostic (4.33e-2)	unprognostic (1.99e-2)	unprognostic (1.00e-1)	unprognostic (1.11e-1)	unprognostic (8.50e-3)	unprognostic (1.41e-1)	unprognostic (4.11e-2)	unprognostic (1.35e-1)	unprognostic (2.44e-1)	unprognostic (3.68e-3)	unprognostic (1.19e-1)	0.1	0	0.1	0.1	0.1	0	0.1	0.3	0.1	0.1	0.1	0.1	0.1	2.2	0.1	0.1	0.3	0	0.1	2	0.1	0	0.6	49.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0	0.1	0.1	0.1	0.1	0	2.5	0.1	0.1	6	0	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0	0	0.2	0	0	0.2	0	0.3	0	0.2	0.3	0.3	0	0.1	0	0	0	5.8	0.2	0.1	0.1	0	0.1	0	0.1	0	0	0.2	0.1	0.4	0.3	6.1	0.2	0.2	0.1	0.4	0.2	0	0.1	0	0.1	0	0	0	0.5	0	0	0	0	0.3	0	0	0.1	0.1	0	0.3	0.1	0.1	1	0	0	0	0	0	0.2	0	0.2	0	0	0	0	0	0	0.1	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0.1	0.1	0.3	0.1	0.1	0	0.1	0.1	0.3	0.1	0	0	0	0	0	0	0.3	15.3	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	2.4	0	0	0	487.3	50.7	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0.2	0	0	0	0	0	0	Ito cells
HECW2	KIAA1301, NEDL2	ENSG00000138411	HECT, C2 and WW domain containing E3 ubiquitin protein ligase 2	Q9P2P5	2	196189099-196593692	Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins	Ubl conjugation pathway	Transferase	Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in many			Cell type enriched	Detected in many	7	Ito cells: 134.4	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Cell type enhanced	Detected in some		neutrophil: 7.7;non-classical monocyte: 5.2	Group enriched	Detected in many	9	granulocytes: 7.7;monocytes: 5.2	Cell line enhanced	Detected in many		HDLM-2: 27.2;HUVEC TERT2: 15.3;SCLC-21H: 17.8;TIME: 20.1;U-138 MG: 12.3	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA034609	Enhanced											HPA034609: AB_10669993	unprognostic (2.65e-2)	unprognostic (3.89e-1)	unprognostic (1.42e-1)	unprognostic (9.00e-3)	unprognostic (2.55e-1)	unprognostic (4.28e-2)	unprognostic (7.63e-3)	unprognostic (1.23e-1)	unprognostic (2.61e-2)	unprognostic (7.05e-2)	unprognostic (4.16e-2)	unprognostic (2.27e-1)	prognostic unfavorable (5.18e-5)	unprognostic (8.05e-3)	unprognostic (5.20e-2)	unprognostic (1.49e-1)	unprognostic (4.48e-2)	8.8	3.3	6.7	2.6	12.6	0.6	4.2	15.7	17.2	4.6	1.2	11.6	0	1.1	3	1	5.5	6.3	4.8	14	6.7	4.3	3.4	5.6	16.4	3.5	8.2	9.3	1.3	2.1	14.7	5.9	15.5	9.5	1.5	1.3	1.2	2.2	1.3	2.7	2.7	1.7	3.1	5.8	11.6	2.1	5.8	8.8	0	7.9	1.6	4.2	2.4	2.5	0.6	0.7	7.7	5.2	0	0.1	0.1	0	0.8	1.2	0	0.7	2.4	0.9	1.5	4	1.2	1.5	0.1	0	0.7	0.3	7.3	1.9	1.7	0.5	0.1	2.5	27.2	0.9	0	1.1	0.1	0.1	0.2	0.2	0.6	0.7	9.1	3.2	2.3	15.3	0	0.1	0	3.7	1	0	0.3	1.4	0.1	0.6	0	0.3	0	0	0	17.8	1.4	1.1	0.2	0	0.2	0	0.1	20.1	12.3	0.8	2.6	0.3	0.1	0	0.7	3.1	0	0.1	0.2	0.5	1.3	0	1.9	0	0.5	0.1	0	0.7	0.6	0.1	0	7.7	0	5.2	0	0.1	0.1	6.7	12.6	15.7	17.2	6.7	4.3	8.2	9.3	9.5	8.8	0	8.9	2.7	0.2	1.9	7.8	14.2	0	1.4	0	0	0	0.1	0	0	9.7	18	0	0	0	0.2	1	0.1	1.1	1.5	0.1	0	2.4	134.4	11.6	3.6	0	1.1	3.3	1	0	12.5	0.1	0	2.5	0	0.9	0	2.1	0.5	6.4	1.4	0.1	1.9	0	0.4	Ito cells
FCN3	FCNH, HAKA1	ENSG00000142748	Ficolin 3	O75636	1	27369112-27374824	Disease related genes, Plasma proteins, Predicted secreted proteins	Complement activation lectin pathway, Immunity, Innate immunity			Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	5	liver: 83.2;lung: 153.7	Cell type enriched	Detected in many	14	Ito cells: 3886.1	Low cancer specificity	Detected in many			Low region specificity	Detected in single			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		hTCEpi: 2.8;MCF7: 2.2;U-2197: 2.2									CAB025945	Approved				Secreted to blood			22800000000	33000000000			CAB025945: 	unprognostic (1.59e-1)	unprognostic (5.25e-2)	unprognostic (1.55e-2)	unprognostic (8.27e-2)	unprognostic (1.45e-3)	unprognostic (1.27e-2)	unprognostic (1.87e-3)	unprognostic (1.21e-1)	unprognostic (6.28e-4)	unprognostic (7.07e-2)	unprognostic (2.86e-2)	unprognostic (3.23e-2)	unprognostic (3.87e-3)	unprognostic (4.14e-2)	unprognostic (1.02e-1)	unprognostic (6.97e-2)	unprognostic (1.61e-2)	7.2	5	0.1	1.7	0.2	0	21.2	0.1	0.3	0.3	0.6	0.4	0.1	0.2	0.3	0.1	1	0.5	0.5	25	0.4	0	13	83.2	153.7	1	0.1	0.1	0.3	2.3	0.7	2.1	6.7	1.1	0.5	0.2	0.8	0.4	0.2	1	0.3	0.7	0.6	0.2	2.7	0.8	0.5	0.2	0.1	9.1	0.3	0.3	1	0.7	0	0	0	0	0	0.1	0	0.5	1.2	0.8	0	0	0	1.2	1.2	0	0	0	0	0.8	0.4	0.6	0	1	1.1	0	0.4	0	0	0.8	0.8	0	0	0	0.3	0.2	0	2.8	0	0	0.1	0	0	0	0	0	2.2	0	0.4	0	0.3	0	0	0.7	0	0	0	0	0	1.1	0	0	0.7	0.6	0	0	0.4	0.3	2.2	0.2	0.3	0.1	0.5	0.4	0.4	1	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0.1	0.2	0.1	0.3	0.4	0	0.1	0.1	1.1	0.2	0	15.2	66.2	0.3	0.7	0	2	81.5	4	0	0	0	0	0	0.1	1.1	99.1	0	93.5	0	0	0.2	0.4	3.5	6.8	0.3	0	0	3886.1	270.1	2.2	3.1	0.7	0	1	0	0	0	0	0.4	0	0	0	0.9	0.4	0.6	1	0	8.6	0	0.3	Ito cells
HSPG2	perlecan, PRCAN, SJS1	ENSG00000142798	Heparan sulfate proteoglycan 2	P98160	1	21822245-21937297	Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins	Angiogenesis		Disease mutation	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		smooth muscle: 104.4	Cell type enriched	Detected in many	7	Ito cells: 621.2	Low cancer specificity	Detected in all			Low region specificity	Detected in many			Cell type enriched	Detected in single	12	plasmacytoid DC: 3.0	Lineage enriched	Detected in single	12	dendritic cells: 3.0	Cell line enhanced	Detected in many		EFO-21: 46.8;HUVEC TERT2: 103.4;TIME: 82.5	Low region specificity	Detected in many			Low region specificity	Detected in many			CAB009820, HPA018892, CAB020718, HPA072690	Approved		Approved	Nucleoplasm,Plasma membrane,Cytosol	Secreted to extracellular matrix				1700000000	Nucleoplasm, Plasma membrane, Cytosol		CAB009820: AB_2119229, CAB020718: , HPA018892: AB_1850597, HPA072690: 	unprognostic (1.61e-1)	unprognostic (1.57e-2)	unprognostic (4.93e-2)	unprognostic (9.60e-2)	unprognostic (2.38e-2)	unprognostic (8.56e-2)	unprognostic (4.55e-1)	unprognostic (1.90e-2)	unprognostic (9.35e-2)	unprognostic (2.19e-3)	unprognostic (5.82e-2)	unprognostic (2.83e-1)	unprognostic (1.21e-3)	unprognostic (1.17e-2)	unprognostic (4.86e-2)	unprognostic (1.46e-2)	prognostic unfavorable (2.82e-4)	54.8	12.8	1.1	22.9	1.5	0.2	19.8	0.8	1.5	37.3	32.3	2.4	37.2	6.2	62.8	37.6	32.7	20.6	60	30.2	1.2	1.2	15.7	8.9	12.5	7.8	2.5	1.2	19.8	9.4	4.6	3.4	24.6	3.8	32	2.5	24.6	15.5	22.3	20.8	12.2	13.7	104.4	1.8	16.4	18.9	11.4	0.7	3.4	16.9	20.1	8.5	66.2	28.2	0.2	3	0	0	0	0.2	0	7	6.5	2.2	7.7	22.6	17.2	8.6	10.7	2.7	3.1	2.8	7.9	14.5	0.5	46.8	16.5	0.1	4.4	0.5	5.2	0.7	0.1	0.7	2.4	7	5.7	4.7	0	0.6	10.4	1.6	3.2	0.9	4.7	103.4	0	3.1	0.9	4.2	1.9	0	3.2	1.9	3.2	2.9	1	9.2	0.9	6	0.9	0.2	0.6	8.1	3.4	4.7	2	1.3	1.2	82.5	6.1	8	4.7	0.3	0	1	0.4	1.6	0	9.1	0	0	0	0	0	0	0.2	0	0	0.1	0.1	0.2	0.1	0	0	0	3	0	0	1.1	1.5	0.8	1.5	1.2	1.2	2.5	1.2	3.8	0.7	65.5	28.7	5.2	10.9	23.5	0.7	4.5	40.8	1.4	12.5	87.2	0	9.4	0	63.1	1	75	34.2	0	21.9	85.1	58.4	6.6	22	2.8	6.1	3.2	2.4	621.2	31.6	2.2	69.6	3.5	57.3	2.8	12.8	1.4	55.1	20.7	65	0.5	0.5	32.3	38.8	0.4	4.1	15.6	7.8	6.4	13.9	8.3	Ito cells
CRHBP	CRF-BP, CRFBP	ENSG00000145708	Corticotropin releasing hormone binding protein	P24387	5	76952713-76981158	Plasma proteins, Predicted secreted proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 24.9;liver: 99.9	Cell type enriched	Detected in some	15	Ito cells: 1768.4	Cancer enhanced	Detected in some		testis cancer: 2.5	Region enhanced	Detected in many		hypothalamus: 24.9	Cell type enriched	Detected in single	4	neutrophil: 1.2	Lineage enriched	Detected in single	4	granulocytes: 1.2	Cell line enhanced	Detected in some		BJ hTERT+ SV40 Large T+: 5.0;BJ hTERT+ SV40 Large T+ RasG12V: 4.9;HBF TERT88: 8.9;RPMI-8226: 3.0;U-698: 9.7;U-87 MG: 5.4;WM-115: 4.6	Low region specificity	Detected in many			Low region specificity	Detected in all			HPA036234, HPA046120	Approved	Supported			Secreted to blood				43000000			HPA036234: , HPA046120: AB_10959760	unprognostic (1.41e-1)	unprognostic (2.00e-2)	unprognostic (1.14e-1)	unprognostic (1.78e-3)	unprognostic (1.18e-1)	unprognostic (1.65e-1)	unprognostic (2.36e-3)	unprognostic (4.44e-5)	unprognostic (2.16e-1)	unprognostic (7.08e-2)	unprognostic (4.98e-4)	unprognostic (1.09e-1)	unprognostic (6.63e-5)	unprognostic (2.76e-2)	unprognostic (4.64e-1)	unprognostic (1.74e-1)	unprognostic (2.95e-2)	8.4	5.6	3.5	0.4	5.4	1.2	2.6	0	7.8	1.6	0.3	3.2	1.8	0.4	1.2	0.7	0.2	0.9	0.5	3.2	4	24.9	16.1	99.9	0.3	0.4	2.7	5.4	0.8	0.2	0.4	0	18.1	1.8	0.6	0.3	1.5	0.6	1.9	0.5	0.2	0.3	0.8	2.2	13.9	0.3	0.5	1.2	0	1.9	0.9	0.4	0.5	0.2	0	0	1.2	0.1	0	0.2	0.8	0	0	0.6	0	0.1	0.1	0	0	0.1	5	4.9	0	0	0	0	0	0.2	0	0	0	8.9	0	0	0.1	0	0	0	0.2	0.7	0	0	3	0.1	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0.3	3	0	0	0	0	0	0	0	0.3	0	0	0	0.5	0	2.6	0	0.1	0	9.7	5.4	0	4.6	0	0.1	0	0.2	0	0	0	0	0	0	0	0	0	1.2	0	0	0	0	0.8	3.5	5.4	0	7.8	4	24.9	2.7	5.4	1.8	1.2	0	0	23.4	0	0.3	0	0.6	22.9	0	0	0	0	0.2	0	0	0.2	18.4	0	0	0.2	0.3	0.4	0	0	4.9	1.6	0	0	1768.4	116.1	0.6	0.3	1	0	0	0	0	0	0	0	1.7	0	0	0	0.1	0.2	0	0	1.3	0	0	Ito cells
FCN2	EBP-37, FCNL, ficolin-2, P35	ENSG00000160339	Ficolin 2	Q15485	9	134880812-134887520	Plasma proteins, Predicted secreted proteins	Complement activation lectin pathway, Immunity, Innate immunity			Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	7	liver: 77.4	Cell type enriched	Detected in some	16	Ito cells: 1725.4	Group enriched	Detected in some	8	breast cancer: 1.0;liver cancer: 2.0;prostate cancer: 1.1;renal cancer: 0.5	Not detected	Not detected			Cell type enhanced	Detected in some		classical monocyte: 6.0;intermediate monocyte: 5.6	Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		RH-30: 1.3;SCLC-21H: 1.1;T-47d: 1.3;U-698: 1.2														Secreted to blood			8100000000	1800000000				unprognostic (1.91e-1)	unprognostic (1.07e-1)			unprognostic (6.96e-4)		unprognostic (3.73e-2)	unprognostic (2.09e-2)		unprognostic (3.81e-1)	unprognostic (2.82e-1)	unprognostic (3.13e-2)	unprognostic (1.06e-2)		unprognostic (1.05e-1)	unprognostic (3.07e-1)		2	11.4	0.2	0.2	0.2	0	4	0.2	0.3	0.2	0.3	0.3	0.5	0	0.3	0.6	0.2	0	0.2	0.5	0.2	0	2.2	77.4	0.2	0.2	0.2	0.2	0.2	0.2	0.2	1.5	0.2	0.3	1.5	0	0.2	1.4	0.2	0.2	0	0.2	0.2	0.2	1.4	0	0.3	0.2	0.2	0.9	0.2	0.2	0.3	0.2	0	3.3	1.3	6	0	0	7.2	0	0	0	0	0	0	0.4	0	0	0.4	0	0	0	0	0	0	0.6	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0.4	0	0	0	1.3	0	0	0	1.1	0	0	0	0	0	1.3	0	0	0	0	0	0	0.4	0	1.2	0	0.9	0	0	6	0	0	5.6	0	0	0	0	3.3	0	0	0	1.3	0	2.5	0	0	7.2	0.2	0.2	0.2	0.3	0.2	0	0.2	0.2	0.3	0.2	0	0	0	0	0	0	0	17.8	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0.4	0	5.9	0	0	0	1725.4	106.9	0	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Ito cells
DNASE1L3	DNAS1L3, LSD	ENSG00000163687	Deoxyribonuclease 1 like 3	Q13609	3	58192257-58214697	Disease related genes, Predicted intracellular proteins, Predicted secreted proteins	Apoptosis, Necrosis	Endonuclease, Hydrolase, Nuclease	Systemic lupus erythematosus	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		blood: 78.1;liver: 72.3;lymphoid tissue: 46.9	Cell type enriched	Detected in many	11	Ito cells: 2006.5	Low cancer specificity	Detected in many			Not detected	Not detected			Cell type enriched	Detected in some	13	plasmacytoid DC: 78.1	Lineage enriched	Detected in many	20	dendritic cells: 78.1	Cell line enhanced	Detected in some		BEWO: 5.4;Karpas-707: 3.2;RPMI-8226: 5.6	Not detected	Not detected			Not detected	Not detected			HPA019955	Approved				Secreted to blood							HPA019955: AB_1847805	unprognostic (7.49e-3)	unprognostic (3.08e-3)	unprognostic (9.75e-3)	unprognostic (3.92e-3)	unprognostic (2.93e-3)	unprognostic (1.01e-2)	prognostic favorable (1.20e-6)	unprognostic (4.74e-4)	unprognostic (2.10e-1)	unprognostic (9.71e-2)	unprognostic (1.91e-3)	unprognostic (6.95e-2)	prognostic favorable (1.06e-7)	unprognostic (7.57e-2)	unprognostic (2.47e-1)	unprognostic (1.57e-1)	unprognostic (5.64e-3)	3.5	7.2	0.5	27.8	0.5	0.1	3.8	0.6	0.5	2.7	6.1	0.5	1.1	6.1	0.9	1.1	4.2	0.8	1.7	3.4	0.5	0.5	14.3	72.3	5.7	38.5	0.5	0.1	1.5	0.8	0	6	2	0.4	1.4	9.2	12	3.3	1.2	0.9	1.8	14	0.4	1.3	46.9	0.8	1.5	0	11	3.9	20.1	17	3.6	3.2	3.8	78.1	0.1	0	0.1	0	0.6	0.2	0.8	0.5	0.3	0.1	0.1	5.4	0.3	0.2	0.3	0.1	1	0.3	0.5	0.4	0	1.3	1.6	0.2	0	0.1	0.2	0.1	0.5	0.8	2.1	0.2	1.1	1.2	0.2	1.1	0.5	0.7	0.2	1.1	0.1	0.5	3.2	0	0.7	0.3	1.3	0.5	0.1	0.4	0.6	0.7	5.6	0.2	0.3	0.8	0.5	0.4	0.4	0.6	0.5	0.4	0.6	0.9	0.7	0.3	0.4	0.3	0.9	0.5	0.8	0.6	0.9	0.3	0	0	0	0	0	0	2.9	0	0	6.1	3.8	0	0	0.1	0.1	0	78.1	0	0.6	0.5	0.5	0.6	0.5	0.5	0.5	0.5	0.1	0.4	0	0	15.6	31.8	0.3	8.1	0	0.6	48.4	0	2.3	0	0	0.1	3.3	0	1.3	29.5	0	46.7	0.3	0.7	3.1	0.4	1.1	21.7	0.4	1.6	0	2006.5	176.2	3.1	3.7	12.8	3.3	55.1	0	0	0	0	24.1	1.8	0.1	0	1.3	0.1	0	14.3	0.2	13.8	0	0.9	Ito cells
BMPER	CRIM3, Cv2	ENSG00000164619	BMP binding endothelial regulator	Q8N8U9	7	33904911-34155872	Disease related genes, Plasma proteins, Predicted secreted proteins			Disease mutation	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in many			Cell type enriched	Detected in some	17	Ito cells: 97.6	Cancer enhanced	Detected in some		glioma: 2.6	Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		ASC diff: 11.8;BJ: 11.2;fHDF/TERT166: 14.5;HBF TERT88: 15.9;HSkMC: 11.9;hTEC/SVTERT24-B: 10.6;U-138 MG: 16.6	Low region specificity	Detected in many			Low region specificity	Detected in many								Secreted to extracellular matrix								unprognostic (4.50e-2)	unprognostic (2.68e-1)	unprognostic (2.83e-2)	unprognostic (3.19e-2)	unprognostic (1.93e-1)	unprognostic (1.96e-4)	unprognostic (5.34e-3)	unprognostic (3.10e-1)	unprognostic (9.98e-3)	unprognostic (3.50e-3)	unprognostic (8.01e-4)	unprognostic (1.96e-1)	unprognostic (5.67e-5)	unprognostic (2.54e-1)	unprognostic (2.62e-1)	unprognostic (2.06e-2)	unprognostic (3.47e-3)	7	1.1	2.2	8.5	6.3	0.3	2.2	9.5	9.7	5	2.4	0.6	0	1.3	3.4	6.7	1.6	1.6	2	2.7	2.4	1.9	1.1	12.9	5.7	7.8	1.6	4.7	3.3	1	0.4	5.3	11.3	6	9.5	2	1.8	1.9	0.9	3.7	1	3.8	2	1.7	1	4.2	1.4	0	0	1.1	2	0.3	1.6	2.1	0	0	0	0	0	0.3	0	0	0.5	0	0	11.8	6.3	0	11.2	2.8	7.1	6.2	0	0	0.1	0	14.5	3.9	5.3	0	0	15.9	0	0.5	0	0.5	0	1.2	0	0	11.9	0	10.6	0	0.6	0	0	0	0	4	0	0	0	0.1	0	0	0	0	0	0	0	0.1	0	1.8	0	0	2.1	0.9	0	0	16.6	1.4	8.2	0	1.4	0	0	6	0	2.8	0	0	0	0	0	0	0	0.1	0	0	0	0.3	0	0	0	0	0	0	0	2.2	6.3	9.5	9.7	2.4	1.9	1.6	4.7	6	0	0	0	0	0.5	0	0.2	4.2	0	0	0	0	5.9	0.4	0	0.1	1.5	0.6	0	0	0	0.2	0.2	0.1	0	0	0.1	0	4.1	97.6	4	0.7	0	0	0	0	0	0.2	0	0	1.1	0	0.3	0	0.8	0	3.9	0.1	0.1	0	0	0.2	Ito cells
CLEC1B	CLEC2	ENSG00000165682	C-type lectin domain family 1 member B	Q9P126	12	9985642-10013424	Predicted intracellular proteins, Predicted membrane proteins	Host-virus interaction	Receptor		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	6	blood: 12.5;liver: 44.1	Cell type enriched	Detected in some	10	Ito cells: 718.7	Not detected	Not detected			Not detected	Not detected			Cell type enhanced	Detected in many		basophil: 7.8	Group enriched	Detected in many	37	dendritic cells: 2.1;granulocytes: 7.8;monocytes: 4.9	Group enriched	Detected in some	6	Karpas-707: 10.1;U-266/84: 23.9	Low region specificity	Detected in single			Not detected	Not detected												1500000				unprognostic (2.03e-1)	unprognostic (2.59e-2)	unprognostic (1.45e-1)		unprognostic (4.63e-3)	unprognostic (1.51e-1)	unprognostic (1.15e-3)	unprognostic (1.26e-2)	unprognostic (7.71e-2)	unprognostic (4.98e-2)	unprognostic (1.58e-1)	unprognostic (8.13e-2)	unprognostic (1.49e-3)	unprognostic (1.46e-2)	unprognostic (1.27e-1)	unprognostic (2.11e-1)	unprognostic (2.91e-2)	0.1	0.3	0	0.4	0.1	4.6	0	0	0	0	0	0	0	0	0	0	0	0.1	0.2	2	0	0	0.1	44.1	2.1	0.2	0	0	0.1	0	0	0.3	0.3	0.2	0	0	0	0	0	0	0.1	0.1	0	0	3.2	0	4.5	0	0	0.2	0	0	0.1	0	0	2.1	7.8	4.9	0.1	0.1	12.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	1.8	0	0	0	1	0	0	0	0	0	0	0	0	0	10.1	0	0	0	0.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0.2	0	0	0	0	0	0	23.9	0	0	2.9	0	7.8	4.9	6.7	0	4	0	0	0	0	2.1	0	0.1	0	3.3	0.1	3.7	1.2	0	12.5	0	0.1	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0.4	10.2	0	0	0	0	0	0	0	4.9	0.1	0	0	0	0	0.2	0	0	3.9	0.1	0	0	718.7	73.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	Ito cells
BTNL9	BTN8, FLJ32535	ENSG00000165810	Butyrophilin like 9	Q6UXG8	5	181040225-181061523	Predicted membrane proteins				Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		adipose tissue: 128.2;breast: 76.8	Cell type enriched	Detected in many	5	Ito cells: 138.7	Low cancer specificity	Detected in many			Low region specificity	Detected in many			Cell type enhanced	Detected in some		memory B-cell: 3.8	Group enriched	Detected in many	6	B-cells: 3.8;granulocytes: 1.3	Group enriched	Detected in some	4	OE19: 7.5;U-698: 28.3	Not detected	Not detected							HPA043429			Approved	Nuclear membrane,Vesicles						Nuclear membrane	Vesicles	HPA043429: AB_10961264	unprognostic (2.69e-1)	unprognostic (1.44e-2)	unprognostic (5.76e-2)	prognostic unfavorable (7.51e-4)	unprognostic (2.07e-1)	unprognostic (1.43e-1)	prognostic favorable (1.55e-9)	unprognostic (2.15e-2)	unprognostic (8.51e-2)	unprognostic (1.78e-1)	unprognostic (1.93e-3)	unprognostic (1.38e-1)	unprognostic (1.03e-1)	unprognostic (2.71e-2)	unprognostic (3.43e-1)	unprognostic (2.50e-1)	unprognostic (4.56e-2)	128.2	2.5	1.5	5.3	1.7	0.3	76.8	1	1.8	3.2	11.3	0.8	3.5	0.7	3.9	3.7	2.9	6	3.7	11	3.4	1.3	3.4	3	25.4	2.7	2.5	1.2	1	2	3	1.6	4.3	1.5	3.4	1.5	3.8	3	3.5	34.4	2	1.9	3.2	2.1	12.7	2	3	0.9	1.1	6.1	4	5.5	3.1	18.3	3.8	0.4	1.3	0.3	0.3	0.2	0.1	0	0.1	0.1	0.1	0	0	1.4	0	0	0	0	2.6	0.1	0.2	1.1	0	0	0.2	0.5	0	0	0.2	2.9	1.1	0.2	0.1	0	0.5	3.3	0	0.1	0	0	0	0	2.8	0.7	0.3	0	0.1	0.1	0.1	0.1	7.5	1.8	0	0.2	0.1	0	0.5	0.1	0	0.1	0	0	0.2	0.4	0	0	0.1	4.4	0.1	0	0.2	0.1	28.3	0.1	0	0	1	0.3	0.5	0.2	0.1	0.1	3.8	0.2	0.2	0.1	1.9	0.2	0.2	1.3	0.3	0.1	0.4	0	0.1	1.5	1.7	1	1.8	3.4	1.3	2.5	1.2	1.5	0.9	0	6.7	3	0.6	2.1	0.4	27.4	0	4	1.2	0	0	0	3.3	0	0.3	29.2	0	0	0.2	0.1	0.2	0.3	1.1	0.4	0.1	0	4.1	138.7	12.7	1.1	2	1	3.3	0	4	0.2	0.1	0	0.4	0	0.3	12.9	2.1	4.3	11.1	1.9	0.1	0.5	1.1	0.6	Ito cells
NPR1	ANPa, ANPRA, GUCY2A, NPRA	ENSG00000169418	Natriuretic peptide receptor 1	P16066	1	153678637-153693992	Enzymes, FDA approved drug targets, Predicted membrane proteins	cGMP biosynthesis	Lyase, Receptor, Vasoactive	FDA approved drug targets	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		breast: 98.4	Cell type enriched	Detected in many	10	Ito cells: 136.2	Cancer enhanced	Detected in all		ovarian cancer: 39.2	Low region specificity	Detected in single			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	6	ASC diff: 60.5	Region enriched	Detected in many	5	olfactory region: 23.0	Region enhanced	Detected in single		olfactory region: 11.1	HPA031087			Approved	Nucleoplasm,Nucleoli,Plasma membrane						Nucleoli	Nucleoplasm, Plasma membrane	HPA031087: AB_10601975	unprognostic (2.54e-1)	unprognostic (3.03e-3)	unprognostic (6.31e-2)	prognostic unfavorable (3.97e-4)	unprognostic (1.55e-1)	unprognostic (6.60e-2)	unprognostic (1.54e-2)	unprognostic (2.03e-1)	unprognostic (2.46e-1)	unprognostic (3.27e-2)	prognostic favorable (2.49e-4)	unprognostic (1.27e-1)	unprognostic (6.69e-2)	unprognostic (1.16e-2)	unprognostic (1.09e-1)	unprognostic (4.06e-1)	unprognostic (1.74e-2)	41.1	4.3	0.5	5.9	0.9	0.1	98.4	0.5	0.8	8.1	8.2	0.3	7.3	1.2	16.8	11.1	8.7	25	9.3	19.6	0.9	0.5	28.7	3.7	34.8	8.6	0.7	0	19.5	4.2	7.8	4.5	11.8	2.5	4.9	1.5	2	2	9	6.9	3.4	4.6	15.6	2.2	1.2	5	6.4	0.2	0.8	7.6	5.1	1.1	11.6	26.5	0	0.5	0	0.3	0	0	0	0	0.4	0	0	60.5	0.2	0	0	0	0	0	0	0.2	0	0.2	0	0	0	0	0	0	0	0.2	0	10	0	7.2	0	0	0.1	0	0.1	0	0	1.2	0	0	0	0	0	0	0	0.3	0	0	5.7	0	0	0.8	0	0	0	0.6	0	2	0.4	0	0	0	0	0	3	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0.5	0.9	0.5	0.8	0.9	0.5	0.7	0	2.5	0.2	0	5.8	0	0.4	1.3	0	4.8	5.1	0	0	14	0	0.1	0	0.6	8	14.2	0	0	0	0.9	3.9	0.4	0	1.5	0.2	0	0	136.2	6	7.9	9.5	0	0	9	0	0	0.7	0	3.9	2.8	0	0	0.9	0.2	0.1	0.9	0.6	0	0	0	Ito cells
F2R	CF2R, PAR-1, PAR1, TR	ENSG00000181104	Coagulation factor II thrombin receptor	P25116	5	76716043-76735781	FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins	Blood coagulation, Hemostasis	G-protein coupled receptor, Receptor, Transducer	FDA approved drug targets	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		lymphoid tissue: 67.5	Cell type enriched	Detected in many	9	Ito cells: 323.5	Low cancer specificity	Detected in all			Low region specificity	Detected in many			Cell type enhanced	Detected in many		gdT-cell: 17.6	Lineage enriched	Detected in many	4	T-cells: 17.6	Cell line enhanced	Detected in many		hTERT-RPE1: 39.1;HUVEC TERT2: 71.3;WM-115: 67.2	Low region specificity	Detected in many			Low region specificity	Detected in all			CAB008973, CAB012962	Approved											CAB008973: , CAB012962: AB_2533198	unprognostic (3.03e-1)	unprognostic (7.76e-2)	unprognostic (5.55e-2)	unprognostic (7.76e-2)	unprognostic (7.14e-2)	unprognostic (3.46e-1)	unprognostic (2.51e-1)	unprognostic (3.75e-2)	unprognostic (5.37e-2)	unprognostic (1.36e-1)	unprognostic (1.36e-1)	unprognostic (2.22e-1)	prognostic unfavorable (2.21e-7)	unprognostic (2.72e-3)	unprognostic (1.30e-1)	unprognostic (1.12e-1)	unprognostic (6.74e-3)	12.3	11.2	1.5	7.5	2.2	1.1	8.9	0.8	3.5	11.7	14	3.3	20.1	5.9	17.6	8.6	9.3	3.5	20.8	19.2	1.4	1.7	19.5	22.6	24.4	10.4	1.5	1.8	6.2	4	1.6	4.7	32	2.5	9.6	5.1	9.6	26.4	14	7.2	23.7	15.5	8.4	3.5	67.5	4.5	16.6	1.4	4	9.1	11.4	13.5	10.7	4.7	0.4	0.2	0.8	0.3	4.2	17.6	6.4	1	3.3	10.5	1.7	19.8	34.7	0.5	5.8	20	3.8	13.9	0.7	9.1	0	9.9	2.5	17.4	2.5	4.5	3.5	7.3	0.8	3.7	22.8	0.7	2.8	29.9	0.1	0.9	19.5	11.9	7.3	2	39.1	71.3	4.1	4.2	4.3	7.8	0.4	1.7	0	3.3	0	18.2	3.2	6.3	0.8	18.1	0.1	1.2	5.7	1.7	0	8.5	9.9	0.1	0.2	32.6	24.3	5.4	0.2	10.8	11.7	3.4	0	6.4	0.4	67.2	0.5	0.2	0.3	17.6	0.3	4.4	0.4	4.1	12.1	0	0.1	0.7	9.1	0.8	4.2	0.1	0.2	0.4	6.4	1.5	2.2	0.8	2.1	1.4	1.7	1.5	1.8	2.5	1.4	0	11.6	1.5	0.5	15.2	2.5	2	10.2	4	3.4	7	0	0.1	0	1.9	8.8	22.6	0.2	0	1.9	0.3	28.8	1.2	5.8	2.5	1.6	0	6.3	323.5	25.7	3.6	0.9	1.3	11.8	0	3.2	0	6.7	0	9.9	2.2	1.6	0	17.5	6.7	4.1	35	0.2	30.2	1	0.4	Ito cells
CLEC4G	LSECtin, UNQ431	ENSG00000182566	C-type lectin domain family 4 member G	Q6UXB4	19	7728957-7733906	Predicted membrane proteins	Host-virus interaction	Host cell receptor for virus entry, Receptor		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	4	liver: 63.1;lymphoid tissue: 53.5	Cell type enriched	Detected in some	13	Ito cells: 979.0	Low cancer specificity	Detected in some			Region enriched	Detected in many	5	cerebellum: 11.8	Cell type enhanced	Detected in some		classical monocyte: 13.9;myeloid DC: 11.9	Group enriched	Detected in many	19	B-cells: 4.1;dendritic cells: 11.9;monocytes: 13.9	Cell line enhanced	Detected in some		ASC TERT1: 1.3;hTEC/SVTERT24-B: 1.0;RPMI-8226: 1.3;RT4: 1.2;TIME: 2.7;U-937: 2.2	Not detected	Not detected			Low region specificity	Detected in all			CAB003789, HPA014044	Enhanced											CAB003789: , HPA014044: AB_1846916	unprognostic (7.20e-2)	unprognostic (1.20e-1)	unprognostic (1.12e-1)	unprognostic (3.64e-1)	unprognostic (4.47e-2)	unprognostic (1.35e-1)	unprognostic (7.98e-2)	unprognostic (1.64e-1)	unprognostic (2.23e-1)	unprognostic (3.29e-2)	unprognostic (7.45e-2)	unprognostic (3.04e-1)	unprognostic (2.13e-8)	unprognostic (5.21e-2)	unprognostic (1.27e-1)	unprognostic (1.77e-1)	unprognostic (6.65e-2)	11.2	0.1	0.9	1.5	1.2	0.9	2.6	11.8	1.6	0.2	1.5	0.2	0.2	0.4	0.2	1.3	5.2	2.7	1	7.3	2.6	1	0.3	63.1	0.5	53.5	0.8	0.2	0.5	0.8	0	0.2	0.8	0.2	0.8	0.7	0.3	4.9	0.5	0.2	0.4	0.7	0.7	0.2	1.3	0.3	0.7	0.2	0.3	0.5	0.6	0.2	2	0.6	4.1	11.9	0.5	13.9	0.4	0.1	2.8	0	0	0	0	0	1.3	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0.3	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0.1	0	0.4	0	0	0	0	0	0	0.7	1.3	0	1.2	0.1	0	0.2	0	0	0	0.6	0.7	2.7	0	0.1	0.7	0	0.1	0	0.3	0	2.2	0.1	0	13.9	0	0	3.3	0	0.3	0	0	11.9	4.1	0.1	0	0.5	0.4	0.4	0.6	0	2.8	0.9	1.2	11.8	1.6	2.6	1	0.8	0.2	0.2	0.2	0	0	9.3	0	0.1	0	0.4	7.6	0	1.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.4	0.7	0	0	979	76.3	0	0.3	2	0	0	0	0	0	0	0	0	0	0	0	0.5	0.7	0.3	0.2	0	0	0	Ito cells
FAM167B	C1orf90, MGC10820	ENSG00000183615	Family with sequence similarity 167 member B	Q9BTA0	1	32247233-32248856	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	4	vagina: 91.1	Cell type enriched	Detected in some	10	Ito cells: 188.4	Cancer enhanced	Detected in all		melanoma: 46.6	Low region specificity	Detected in many			Cell type enhanced	Detected in some		T-reg: 4.5	Lineage enriched	Detected in many	4	T-cells: 4.5	Cell line enhanced	Detected in some		BJ hTERT+: 7.0;EFO-21: 8.9;SK-MEL-30: 21.5;U-2197: 22.0	Not detected	Not detected			Not detected	Not detected			HPA029398, HPA062074	Uncertain		Approved	Actin filaments						Actin filaments		HPA029398: AB_10602807, HPA062074: AB_2684677	unprognostic (2.16e-1)	unprognostic (2.06e-1)	prognostic unfavorable (1.11e-4)	unprognostic (6.03e-2)	unprognostic (1.74e-2)	unprognostic (3.36e-3)	unprognostic (7.44e-3)	unprognostic (3.64e-1)	unprognostic (3.00e-3)	unprognostic (1.02e-2)	unprognostic (1.30e-2)	unprognostic (8.89e-2)	unprognostic (4.80e-2)	unprognostic (2.69e-2)	unprognostic (1.60e-1)	unprognostic (8.04e-2)	unprognostic (5.08e-2)	17.2	10.5	1.4	5	1.7	0.1	20.1	1.7	1.9	6.1	3.1	1.1	7.4	3.6	7.8	2.2	4.5	3.4	5.5	11.3	1.8	1.7	20.3	18.4	22.4	6.2	3.2	0.6	3.8	6.6	5.2	8.5	5.8	3.3	9.2	2.7	5.2	2.6	8.2	3.3	1.1	4.1	7.5	2.6	1.4	4	1.8	2.7	1.2	11.8	1.5	1.9	7.2	91.1	1	0	0.8	0	0.3	4.5	0.7	0.6	1.3	0.4	0	0.9	0.8	0	3.1	7	1.4	1.9	0	0.6	0.1	8.9	5.2	1.6	1	0.2	0	0.4	0.1	0	0	2.8	0.4	0.3	0	0.1	0.8	0.5	1	0.3	1.8	2.6	0.4	0	0	0.1	0.4	0.1	0	0.2	0.1	3	0.6	0	0.8	0.9	0.3	1.3	0.3	2	0.1	21.5	0.5	0.3	0	2.3	0.6	0.7	22	0	0.1	0.2	0.5	0.2	0.1	0.3	0	0	0.8	2.6	0	0.7	0.5	0.8	0.8	0	1	0.5	1.6	0	0.3	0	0	4.5	0.7	1.4	1.7	1.7	1.9	1.8	1.7	3.2	0.6	3.3	2.7	0	1.4	3.9	0.4	0.2	0.2	0.4	0	0	0	5.2	0	0.1	0	0.4	0	19.1	0	0	0.7	0.3	0.9	0.6	0	1	0.5	0	0	188.4	11.9	0	2.6	0.4	1.7	0	1	0	0.2	0.2	1.1	0	0.6	0	1.2	0	0.2	0.9	0.2	3.3	0.4	0.3	Ito cells
COLEC10	CL-L1	ENSG00000184374	Collectin subfamily member 10	Q9Y6Z7	8	118995452-119106582	Disease related genes, Plasma proteins, Predicted secreted proteins			Disease mutation	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	6	liver: 47.4	Cell type enriched	Detected in single	42	Ito cells: 16.5	Low cancer specificity	Detected in some			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		BJ hTERT+: 8.4;HHSteC: 3.5;SK-BR-3: 15.0	Not detected	Not detected			Low region specificity	Detected in all								Secreted to blood				5700000				unprognostic (1.28e-1)	unprognostic (1.29e-2)	unprognostic (3.79e-4)	unprognostic (6.25e-3)	unprognostic (1.80e-3)	unprognostic (7.73e-2)	prognostic favorable (5.79e-4)	unprognostic (1.05e-1)		unprognostic (1.61e-1)	unprognostic (1.13e-1)	unprognostic (9.25e-2)	unprognostic (9.02e-5)	unprognostic (2.47e-1)	unprognostic (1.82e-1)	unprognostic (5.85e-5)	unprognostic (7.12e-2)	0	0.5	0.1	0	0.1	0	0	0.1	0.1	0	0.1	0	0	0	0	0	0	0	1.3	0.4	0.1	0.1	0.3	47.4	0.7	0.6	0.1	0	0	0	0	0.1	8.5	0.1	2.4	0	0.2	0	0	0	0	0.5	0	0.1	0	0	0	0	0	1.3	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0.1	0	0.2	0	0	0.7	8.4	0.1	0.1	0.1	0.3	0	0.7	0.1	0	0	0	0	0.4	0	0	0	0	0	3.5	0.1	0	0	0	1.2	0	0.2	0	0.1	0	0.3	0.4	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	15	0	0.1	0	0	0	0	0.1	1.2	0	1	0.4	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0.1	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0.1	0	0.3	0	0	0.3	0	0	16.5	0	0	0	0	0	0	0	0	0.1	0	0	0.4	0	0	0	0	0	0.4	0	0	0	0.2	Ito cells
F8	DXS1253E, F8C, FVIII, HEMA	ENSG00000185010	Coagulation factor VIII	P00451	X	154835788-155026940	Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins	Acute phase, Blood coagulation, Hemostasis		Disease mutation, FDA approved drug targets, Hemophilia	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell type enriched	Detected in many	11	Ito cells: 376.3	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Cell line enhanced	Detected in many		U-2197: 15.0	Low region specificity	Detected in many			Low region specificity	Detected in many			CAB018777	Enhanced				Secreted to blood				6400000			CAB018777: AB_640320	unprognostic (2.09e-1)	unprognostic (5.66e-4)	unprognostic (4.94e-2)	unprognostic (8.32e-5)	unprognostic (1.26e-1)	unprognostic (5.05e-2)	unprognostic (6.05e-2)	unprognostic (8.27e-2)	unprognostic (6.58e-2)	unprognostic (1.68e-1)	unprognostic (1.67e-2)	unprognostic (5.58e-2)	unprognostic (1.24e-2)	unprognostic (2.16e-3)	unprognostic (1.69e-1)	unprognostic (1.17e-2)	unprognostic (4.44e-2)	48.9	9.4	6.8	3.1	7.2	1.5	32.2	1.5	8.6	11.9	10.3	2.2	6.1	2.3	11.1	8.5	18.4	5.4	4.4	38	4.9	4.4	17.1	31.3	24.4	25.6	5.6	1.2	18.8	7.2	6	14	2.8	5.1	20.5	3.5	8.8	4	7.1	30.3	2	4.3	12.8	3.3	39	3.2	17.2	1.8	1.1	15.8	15	3	17.5	20.2	2.3	3	5.2	3.3	4	12.9	2.7	4.8	3.9	0.8	1.8	6.1	9.6	0.2	2.6	1.7	1.9	3.1	0.1	5.8	10.4	7.3	2.7	4.2	0.5	0.9	0.9	1.7	4.2	1.5	2.2	2	0	2.9	1.7	5	6.8	0.5	1.6	2.2	3.3	1.1	5.1	0.8	8	9.1	2.3	1.4	1.6	1.2	1.5	4	1.2	1.3	1.4	1.7	1.1	3.2	2.4	6.3	0.6	3.3	1	1.4	4.3	1.1	9.5	4.8	15	2.8	4.7	3.9	5	8.7	10.8	5	3.7	3.3	0.5	6.5	2.8	12.9	2.3	3.9	6.8	3	1.6	2	5.1	5.2	4	2.6	0.4	5.2	2.7	6.8	7.2	1.5	8.6	4.9	4.4	5.6	1.2	5.1	1.8	0	4.6	2.2	1.5	1.5	7.9	14.6	12.7	2.7	2.3	3.5	2	0.9	6.6	2.3	0.9	33.2	0.5	0	0.6	0.7	2.8	1.7	1.1	9.2	2.9	6.4	0	376.3	25.4	1.9	10.6	3.2	0	1.8	0.7	6.5	6.9	0	4.9	8.4	3.3	6.5	3.3	1.6	2.5	1	0.1	4.9	0.4	0.9	Ito cells
RELN	PRO1598, RL	ENSG00000189056	Reelin	P78509	7	103471784-103989516	Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins	Cell adhesion	Developmental protein, Hydrolase, Protease, Serine protease	Disease mutation, Epilepsy, Lissencephaly	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	5	brain: 73.4;liver: 35.8	Cell type enriched	Detected in some	15	Ito cells: 182.3	Cancer enhanced	Detected in many		liver cancer: 5.7	Region enriched	Detected in many	11	cerebellum: 73.4	Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		Hep G2: 34.4;PC-3: 7.0;SCLC-21H: 8.4;SH-SY5Y: 9.1;TIME: 20.0	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA077891			Approved	Golgi apparatus,Vesicles	Secreted to extracellular matrix				59000000	Golgi apparatus	Vesicles	HPA077891: 	unprognostic (1.42e-1)	unprognostic (2.93e-3)	unprognostic (4.31e-2)	unprognostic (1.29e-4)	unprognostic (1.30e-1)	unprognostic (6.95e-2)	unprognostic (1.85e-1)	unprognostic (8.35e-2)	unprognostic (1.54e-1)	unprognostic (1.48e-2)	unprognostic (3.31e-3)	unprognostic (3.86e-1)	unprognostic (2.02e-2)	unprognostic (1.43e-2)	unprognostic (3.03e-1)	unprognostic (1.35e-1)	unprognostic (3.06e-2)	2.7	5.9	5.7	1.2	5.3	0.5	6.3	73.4	6.7	2.9	2.1	0.8	0	1.1	1	3	1.7	4.4	1.9	3.2	5.7	5.3	1.2	35.8	1.6	7.9	1.8	2.5	1.3	1	0.3	0.8	0.4	5.1	1.2	2.1	10.6	1.1	2.1	0.4	1.1	1.9	2.4	3.2	1.1	0.8	1.5	0	0	2.6	1.7	0.9	1.7	2.5	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0.8	0	0.2	0	0	0	0	0	3.7	0	0	1.3	0	0.1	0	0	2.4	0	34.4	0	0	0	0	0	0.3	0	2.2	0.4	0	0	0	0.1	0	0	0	0	0	7	0	1.4	0	0	0	8.4	9.1	0	0	0	0	0	0	20	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	5.7	5.3	73.4	6.7	5.7	5.3	1.8	2.5	5.1	0	0	0	0	0	0.6	11.3	3.1	5.1	0	0	0	0	0	0	0.2	12.3	2.6	0	0	1	0.1	2.4	0.3	0	2.4	0.2	0	0	182.3	9.4	4.8	0	0	0	0	0	0.2	0.2	0	0	0	1.2	0	0.4	0	0.1	0.5	0.2	0	0	0	Ito cells
LYPD2	LYPDC2, RGTR430, UNQ430	ENSG00000197353	LY6/PLAUR domain containing 2	Q6UXB3	8	142750150-142752534	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Group enriched	Detected in some	6	blood: 76.5;esophagus: 77.5;lymphoid tissue: 69.2;tongue: 37.9	Cell type enriched	Detected in single	13	Ito cells: 4.9	Low cancer specificity	Detected in many			Not detected	Not detected			Cell type enriched	Detected in some	13	non-classical monocyte: 76.5	Lineage enriched	Detected in many	20	monocytes: 76.5	Cell line enhanced	Detected in some		EFO-21: 15.1;HaCaT: 4.1;OE19: 2.8	Low region specificity	Detected in many			Not detected	Not detected			HPA028599	Uncertain				Intracellular and membrane							HPA028599: AB_10603777		prognostic favorable (2.00e-4)		unprognostic (3.10e-2)		prognostic favorable (2.63e-4)	unprognostic (3.85e-3)	unprognostic (3.75e-2)	unprognostic (2.49e-1)	unprognostic (1.57e-2)	unprognostic (3.11e-3)		unprognostic (1.53e-1)	unprognostic (2.41e-1)	unprognostic (1.85e-1)	unprognostic (1.12e-1)	unprognostic (2.04e-1)	0	0	0	0.1	0	0.1	0.4	0	0	6.7	0	0	0.1	0	0.3	0	77.5	0.2	0.1	1.2	0	0	0	3.6	0.4	0	0	0	0.3	0	0	0	0.5	0.1	0	0	0.4	7.7	0	0.5	6.5	0	0	0	0.1	11.6	0	0	5.7	0	37.9	69.2	0	10.1	0.2	3.7	0	76.5	0	0	1.5	0	0	0.1	0	0	0	0.3	0	0	0	0	0	0.1	0.1	15.1	0	0	4.1	0	0	0	0	0	0	0	0.2	0	0	0.1	0	0.4	0	0	0	0	0.1	0	0.1	0	0	0	0	0.1	2.8	0	0.1	0	0	0	0	0	0.1	0	0	0	0	0	0	0.5	0	0.1	0	0	0	0	0.1	0	0	0	0	0	0	0	5.8	0	0.2	0	0	3.7	0	0	0	0	0	76.5	0.3	0	1.5	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0.3	0	0	4.9	0.3	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0.4	0.1	0	0	0	Ito cells
SHANK3	KIAA1650, prosap2, PSAP2, SPANK-2	ENSG00000251322	SH3 and multiple ankyrin repeat domains 3		22	50674415-50733298	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level				Tissue enhanced	Detected in many		brain: 32.4	Cell type enriched	Detected in some	5	Ito cells: 90.2	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		HEL: 6.4;TIME: 10.2	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA003446	Enhanced		Approved	Nucleoplasm,Plasma membrane						Nucleoplasm, Plasma membrane		HPA003446: AB_1079958	unprognostic (3.62e-1)	unprognostic (1.08e-2)	prognostic unfavorable (7.40e-4)	unprognostic (6.02e-2)	unprognostic (4.17e-1)	unprognostic (1.72e-3)	unprognostic (3.41e-2)	unprognostic (3.13e-1)	unprognostic (9.67e-2)	unprognostic (5.62e-2)	unprognostic (2.09e-2)	unprognostic (7.52e-2)	unprognostic (2.47e-2)	unprognostic (7.81e-2)	unprognostic (1.19e-1)	unprognostic (4.89e-2)	unprognostic (1.41e-1)	9.5	5.4	23.5	1.3	26.1	2.6	8.7	13	32.4	3.5	2	2.4	0.1	5.2	3.8	3.4	2.5	2.8	1.1	4.4	21.6	2.4	2.9	5.1	5.3	2.9	2.5	18.1	1.6	7.6	7.9	1	1.7	2.6	1.9	1.9	0.6	8.5	3.4	3.6	3.1	6.6	1.5	2	12.3	1.3	3.4	6.4	0.2	4.1	1.4	2.6	5.3	2.7	0	0	0	0	0	0	0	3.5	0.9	0.6	2.9	0.5	0.5	0	0.6	0	0.2	0	0.6	1.7	0	1.2	0.2	1.7	0.6	0.9	0.4	0	0	0	6.4	0.4	1.7	1.5	0.8	0.3	1.6	1.1	0.1	0.3	0.1	2	0.7	0.1	0.1	0.1	0.9	0.5	0.2	1.3	0.7	1.8	1.7	0	0.7	0.3	0.5	1.3	1.9	1.7	0	0.8	0.4	0.3	0.4	10.2	0.2	1.7	0.7	0.4	0.1	0.1	0	0.1	0.5	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	23.5	26.1	13	32.4	21.6	2.4	2.5	18.1	2.6	6.4	0	1.4	0	0	0.2	0.5	19.6	0	1.4	1.2	0	0	0	0	0	1.8	16.8	0	0	0	0	0.2	0.1	0	5.6	0.3	0	2.4	90.2	5.6	0	0	0	0	0	0	1.4	0.1	0	0.4	0.7	0	0	0.9	0.2	0.4	0.3	0	0	0	0.3	Ito cells
CCL23	Ckb-8, CKb8, MIP-3, MPIF-1, SCYA23	ENSG00000274736	C-C motif chemokine ligand 23	P55773	17	36013056-36017968	Cancer-related genes, Plasma proteins, Predicted secreted proteins	Chemotaxis, Inflammatory response	Cytokine, Heparin-binding	Cancer-related genes	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		blood: 50.3	Cell type enriched	Detected in some	13	Ito cells: 276.2	Low cancer specificity	Detected in some							Cell type enriched	Detected in single	173	eosinophil: 50.3	Lineage enriched	Detected in single	173	granulocytes: 50.3	Group enriched	Detected in some	4	HEL: 12.9;THP-1: 27.6									HPA042015	Uncertain				Secreted to blood			937000	57000			HPA042015: AB_10794039	unprognostic (1.65e-3)	unprognostic (1.43e-2)	unprognostic (1.04e-1)	unprognostic (9.50e-2)	unprognostic (3.59e-2)	unprognostic (2.39e-1)	unprognostic (1.20e-4)	unprognostic (2.17e-1)	unprognostic (6.49e-2)	unprognostic (1.08e-2)	unprognostic (7.05e-2)	unprognostic (6.93e-2)	unprognostic (1.35e-3)	unprognostic (2.18e-1)	unprognostic (2.76e-1)	unprognostic (1.20e-2)	unprognostic (1.95e-1)	5.8	0.5	0	13.1	0	2.1	3.7	0	0.5	2.1	2	0	1	0	1.8	3	1.3	1.5	2.2	4.6	0		3	5.9	7.9	8	0.3	0	1.2	0	0	0.5	1.5	0.2	1.7	7.2	0.7	0	1.1	0.5	0.4	1	8.4	0	2	0	0.1	0	0.4	1.1	0.6	0.5	3	0	0.2	0.1	50.3	0.2	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	12.9	0	0	0	1.7	0.9	0	0	0	0	0	0	0	0	0	0	0	0	3.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	27.6	0	0	0	0	0	0	0	0	0	4.7	0	0.2	0.2	50.3	0	0.2	0	0.2	0	0.1	0.1	0	0	0.1	0.2	0	0.2	0	0	0											3	2.9	0	0.2	1.4	0	0.3	0	2.7	1.2	0	0	0	0	0	0.9	9	0.4	0	0	0	0.2	0.1	9.3	1.5	6.8	0	0	276.2	21.2	0	0	1.7	1.7	0	0	0	0	17.8	0	0	0	0	0.3	0	0	2.4	0.2	0.8	0.4	0.1	Ito cells
CCL14	CKb1, HCC-1, HCC-3, MCIF, NCC-2, SCYA14, SCYL2	ENSG00000276409	C-C motif chemokine ligand 14	Q16627	17	35983291-35987004	Cancer-related genes, Plasma proteins, Predicted secreted proteins		Cytokine	Cancer-related genes	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		breast: 80.7;lymphoid tissue: 98.4	Cell type enriched	Detected in many	16	Ito cells: 1401.9	Low cancer specificity	Detected in some							Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	52	HUVEC TERT2: 35.9									CAB004423, HPA030268	Uncertain				Secreted to blood			5200000	19000000			CAB004423: AB_627716, HPA030268: AB_10603782	unprognostic (4.13e-2)	unprognostic (5.85e-2)	unprognostic (4.86e-2)	unprognostic (3.55e-3)	unprognostic (2.50e-1)	unprognostic (1.99e-2)	unprognostic (8.79e-5)	unprognostic (1.44e-1)	unprognostic (1.53e-1)	unprognostic (8.10e-2)	unprognostic (6.33e-3)	unprognostic (3.00e-2)	unprognostic (7.27e-3)	unprognostic (1.36e-2)	unprognostic (3.95e-1)	unprognostic (3.52e-1)	unprognostic (1.14e-1)	56.3	5.1	0	5.9	0	0	80.7	0	0	37.6	8.4	0	16.6	0	37.6	11.1	20.9	9.1	17.3	27.5	0		8.7	34.2	26.4	39.1	0	0	12.4	0.8	2	6.5	0	0	23.5	0.7	4.1	6.5	11.4	21.9	7.5	3.9	19.1	0	98.4	0.2	15	0	1.3	17.6	16.7	6.2	25.3	45.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	35.9	0	0	0	0	0	0	0.1	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0.6	0.2	0	0	0	0.2	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0											0	14.6	7	0.1	1.6	0	0.1	28.1	4	1.2	0	0	0	0	0	22.9	57.6	1.7	0	0	0	0.2	0.2	1.1	5.9	0.2	0	0	1401.9	89.1	43.1	1.4	0	0	0	1	0	0	3.5	0	1	0	0	0.3	0	0	1.3	0	1.3	0.6	0.1	Ito cells
EXOC3L2	FLJ36147, XTP7	ENSG00000283632	Exocyst complex component 3 like 2	Q2M3D2	19	45212621-45245431	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in many			Cell type enriched	Detected in some	10	Ito cells: 57.1									Group enriched	Detected in some	4	basophil: 1.6;neutrophil: 2.5	Lineage enriched	Detected in single	5	granulocytes: 2.5	Group enriched	Detected in some	7	HEL: 18.2;K-562: 16.8									HPA041595, HPA061110	Approved		Approved	Nucleoplasm,Golgi apparatus,Vesicles,Cytosol						Vesicles	Nucleoplasm, Golgi apparatus, Cytosol	HPA041595: AB_10794521, HPA061110: AB_2684431																		3.2	4.3	0	2	0	0.9	3	0	0.3	3.6	2.1	0.1	2.4	2.3	14.5	1.2	2.3	0.6	6.9	1.9	0		12.7	9.4	3.4	6.3	0	0	3.4	2.8	2.4	3.5	0.4	0	3.7	0.2	13.7	3.3	3.6	1	2.4	3.9	1.6	0	12.6	2.4	2.1	0	0	4.6	1.5	3.2	1.6	3.3	0.5	0.3	2.5	0.4	0.2	0.4	0.2	0.1	0.3	2.3	0.2	0	0	0.2	0.1	0	0	0	0.1	0.3	0.1	2.2	0	0.2	1.2	0	0.1	0	0.1	0	18.2	0.5	0.1	0	0	0.1	0	0	0	0	0.2	0.1	0	16.8	0.3	0	0.2	0	0	0.2	0.1	0.5	1.3	0	0.1	0	0.1	0.3	0	0.1	0.1	0.1	0.7	0.1	0.3	0.4	0.8	1.6	0.3	0.1	0.2	0.1	0	0.1	0.2	0.1	1.6	0.4	0.2	0.4	0.2	0.2	0.2	0.2	0.2	0.2	0.5	0.2	0.3	2.5	0.2	0.3	0.3	0.1	0.2											0	2.2	0	0.3	0.3	0.6	0.3	0	0	0	0	0	0	0	0	0.1	6	0	0	0	0	0	0.2	0	0	0	0	0	57.1	1.5	0	1.7	0	0	0	0	0.2	0	0	1.8	0	0.1	0	0.1	0.2	3.4	0.6	0	0	0	0.1	Ito cells
